HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Botitsi, E. Articles by Siafaka-Kapadai, A. Search for Related Content PubMed PubMed Citation Articles by Botitsi, E. Articles by Siafaka-Kapadai, A. Social Bookmarking                      What's this?

The Journal of Lipid Research, Vol. 39, 1295-1304, June 1998
Copyright © 1998 by Lipid Research, Inc.

Original Article

Metabolic fate of platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) in FRTL5 cells

Correspondence to: Athanassia Siafaka-Kapadai.

The metabolism of platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn -glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn -glycero-3-phosphocholine) was investigated in FRTL5 cells, a normal rat thyroid cell line. FRTL5 cells incorporated [³H]PAF and deacetylated this compound to the corresponding [³H]lyso-PAF which was not accumulated or secreted but converted mainly to alkyl-acyl-phosphocholine indicating that this acylation process was particularly active in these cells. Among metabolic products of both [³H]PAF and [³H]lyso-PAF were alkylglycerol as well as its mono- and diacyl derivatives. [³H]alkylglycerol could be the intermediate compound for the production of [³H]alkyl- and [³H]alkenyl-phosphoethanolamine (plasmalogen) which were also metabolic products. FRTL5 cells were able to convert lyso-PAF to PAF especially when they were stimulated by ionophore A23187 in the presence of [³H]lyso-PAF and phenylmethylsulfonyl fluoride. The amount of PAF increased for the first 30 min and declined thereafter. PAF resting levels were found low in the same cells. Furthermore, PAF-acetylhydrolase activity was determined in cell homogenates.

The presence of metabolic products such as alkyl-phosphatidylcholine, alkyl- and alkenyl-phosphatidylethanolamine and alkyl-glycerol, as well as, its mono- and diacyl derivatives, indicates that FRTL5 cells and probably other thyroid cells, are very active in metabolizing PAF and lyso-PAF and suggests the co-operation of the corresponding metabolic pathways in these cells.—Botitsi, E., M. Mavri-Vavayanni, and A. Siafaka-Kapadai. Metabolic fate of platelet activating factor (PAF, 1-O-aklyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) in FRTL5 cells. J. Lipid Res. 1998. 39: 1295–1304.

Supplementary key words: PAF metabolism, PAF biosynthesis, PAF-acetylhydrolase, plasmalogens, alkylglycerol, FRTL5 cells, thyroid

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Mariggio, J. Sebastia, B. M. Filippi, C. Iurisci, C. Volonte, S. Amadio, V. De Falco, M. Santoro, and D. Corda A novel pathway of cell growth regulation mediated by a PLA2{alpha}-derived phosphoinositide metabolite FASEB J, December 1, 2006; 20(14): 2567 - 2569. [Abstract] [Full Text] [PDF]

				Y. Denizot, T. Chianea, F. Labrousse, V. Truffinet, M. Delage, and M. Mathonnet Platelet-activating factor and human thyroid cancer Eur. J. Endocrinol., July 1, 2005; 153(1): 31 - 40. [Abstract] [Full Text] [PDF]